Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Asian Journal of Surgery |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958424015276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846102009749438464 |
|---|---|
| author | Xiaohong Mu Yunfang Wang Zhengye Fan Kang Yi |
| author_facet | Xiaohong Mu Yunfang Wang Zhengye Fan Kang Yi |
| author_sort | Xiaohong Mu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-adfa3ef5e2fd4f70b1011f60e35cd0e5 |
| institution | Kabale University |
| issn | 1015-9584 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Surgery |
| spelling | doaj-art-adfa3ef5e2fd4f70b1011f60e35cd0e52024-12-28T05:21:12ZengElsevierAsian Journal of Surgery1015-95842025-01-01481805806Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trialsXiaohong Mu0Yunfang Wang1Zhengye Fan2Kang Yi3Department of Cardiovascular Medicine, Huanxian People's Hospital, Qingyang, 745700, ChinaGansu Provincial Hospital, Lanzhou, 730000, ChinaThe First Hospital of Longnan City, Longnan, 742500, ChinaCorresponding author. Department of Cardiovascular Surgery, Gansu Provincial Hospital, No. 204, Donggang West Road, Lanzhou City, Gansu Province, 730000, China.; Gansu Provincial Hospital, Lanzhou, 730000, Chinahttp://www.sciencedirect.com/science/article/pii/S1015958424015276 |
| spellingShingle | Xiaohong Mu Yunfang Wang Zhengye Fan Kang Yi Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials Asian Journal of Surgery |
| title | Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials |
| title_full | Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials |
| title_fullStr | Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials |
| title_full_unstemmed | Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials |
| title_short | Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy alone for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials |
| title_sort | safety and efficacy of immune checkpoint inhibitors icis plus chemotherapy versus chemotherapy alone for small cell lung cancer sclc a systematic review and meta analysis of randomized controlled trials |
| url | http://www.sciencedirect.com/science/article/pii/S1015958424015276 |
| work_keys_str_mv | AT xiaohongmu safetyandefficacyofimmunecheckpointinhibitorsicispluschemotherapyversuschemotherapyaloneforsmallcelllungcancersclcasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT yunfangwang safetyandefficacyofimmunecheckpointinhibitorsicispluschemotherapyversuschemotherapyaloneforsmallcelllungcancersclcasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhengyefan safetyandefficacyofimmunecheckpointinhibitorsicispluschemotherapyversuschemotherapyaloneforsmallcelllungcancersclcasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT kangyi safetyandefficacyofimmunecheckpointinhibitorsicispluschemotherapyversuschemotherapyaloneforsmallcelllungcancersclcasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |